Back to DAVENPORT & Co LLC DAVENPORT & Co LLC

LTRNLTRN
Showing 9 of 10 quarters

Position history for DAVENPORT & Co LLCDAVENPORT & Co LLC's holdings in LANTERN PHARMA INC

Yes. Davenport holds 23,814 shares of LTRN (Lantern Pharma), worth $24,052, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Davenport has held LTRN since Q2 2024, across 10 quarterly 13F filings.

Current Value

$24,052

Current Shares

23,814

Total Value Change

-$173,445

Total Shares Change

-30,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
23,814
0.0%
$24,0520.0%$1.01
0
2026-Q2
Unchanged
23,814
0.0%
$99,3040.0%$4.17
0
2026-Q1
Unchanged
23,814
0.0%
$32,6250.0%$1.37
0
2025-Q4
Decreased
23,814
-7.8%
$72,1560.0%$3.03
0
2025-Q3
Unchanged
25,814
0.0%
$112,2910.0%$4.35
0
2025-Q2
Unchanged
25,814
0.0%
$81,5720.0%$3.16
0
2025-Q1
Unchanged
25,814
0.0%
$91,3820.0%$3.54
0
2024-Q4
Decreased
25,814
-52.0%
$82,3470.0%$3.19
0
2024-Q3
Decreased
53,814
-15.7%
$197,4970.0%$3.67
0

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used